Detalles de la búsqueda
1.
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
J Hepatol
; 78(5): 926-936, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062574
2.
[Evolution of hepatitis C virus genotype 1a vs. 1b distribution in Germany between 2004 and 2018 - An analysis of 17093 patients from different real world registries]. / Veränderungen der Hepatitis-C-Virus-Genotyp-1a/1b-Verteilung zwischen 2004 und 2018 in Deutschland eine Analyse von 17093 Patienten aus verschiedenen Real-World-Registern.
Z Gastroenterol
; 59(3): 241-249, 2021 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-33684956
3.
Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era.
Clin Infect Dis
; 71(5): 1248-1254, 2020 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562816
4.
Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?
J Clin Gastroenterol
; 54(2): 192-199, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30789853
5.
Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R).
Z Gastroenterol
; 58(9): 841-846, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32947629
6.
Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy - data from the German hepatitis C registry (DHC-R).
Z Gastroenterol
; 58(4): 341-351, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32040979
7.
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment.
J Viral Hepat
; 26(2): 224-230, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315694
8.
Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C.
Z Gastroenterol
; 57(2): 139-147, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30754058
9.
Evolution of HCV patient characteristics and DAA regimens in the German Hepatitis C Registry (DHC-R) in 2014 and 2015.
Z Gastroenterol
; 57(5): 584-592, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31083746
10.
[4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)]. / Deutsches Hepatitis C-Register (DHC-R) eine Zwischenbilanz 4 Jahre nach Zulassung direkt antiviraler Substanzen (DAAs).
Z Gastroenterol
; 57(1): 27-36, 2019 Jan.
Artículo
en Alemán
| MEDLINE | ID: mdl-30641600
11.
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C.
J Hepatol
; 68(4): 663-671, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133244
12.
Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03).
J Med Virol
; 90(2): 304-312, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28710853
13.
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study.
J Hepatol
; 67(5): 918-924, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28736139
14.
Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).
Clin Infect Dis
; 63(10): 1320-1324, 2016 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27535952
15.
Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R).
Viruses
; 14(7)2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891520
16.
Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C-Results from the German Hepatitis C-Registry (DHC-R).
Biomedicines
; 9(10)2021 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34680612
17.
Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry.
Eur J Gastroenterol Hepatol
; 33(3): 415-423, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32345848
18.
[Current recommendations for the treatment of chronic hepatitis C]. / Aktuelle Empfehlung zur Therapie der chronischen Hepatitis C
Z Gastroenterol
; 52(10): 1185-97, 2014 Oct.
Artículo
en Alemán
| MEDLINE | ID: mdl-25473687
19.
Aktuelle Empfehlung zur Therapie der chronischen Hepatitis C
Z Gastroenterol
; 52(10): 1185-97, 2014 Oct.
Artículo
en Alemán
| MEDLINE | ID: mdl-25513400
20.
Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry.
Drugs Aging
; 35(9): 843-857, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30084012
Resultados
1 -
20
de 20
1
Próxima >
>>